Medic

Medic Life Sciences is a biotechnology company leveraging CRISPR-based functional genomics and a proprietary 3D cell culture platform to revolutionize drug discovery for cancer. The company's technology allows for the systematic identification of genetic vulnerabilities in cancer cells, enabling the discovery of novel therapeutic targets that are often missed by traditional methods. By combining high-throughput screening with advanced computational analysis, Medic aims to develop a pipeline of precision medicines tailored to specific genetic profiles. The company is currently focused on advancing its internal programs toward clinical validation while exploring strategic partnerships to expand the reach of its discovery engine.